Literature DB >> 15751060

HLA-B27-restricted CD8+ T cell response to cartilage-derived self peptides in ankylosing spondylitis.

Pamir Atagunduz1, Heiner Appel, Wolfgang Kuon, Peihua Wu, Andreas Thiel, Peter-Michael Kloetzel, Joachim Sieper.   

Abstract

OBJECTIVE: Several hypotheses have been proposed to explain the strong association between HLA-B27 and ankylosing spondylitis (AS). Among these, the arthritogenic peptide theory proposes that certain B27 subtype alleles bind specific arthritogenic peptide(s) due to their unique amino acid anchor residues. Cartilage antigens have been discussed as candidate targets for the immune response in AS. The recognition of HLA-B27-peptide complexes by self-reactive CD8+ T cells might contribute to joint-specific tissue damage. Therefore, we investigated the presence of autoreactive CD8+ T cells specific for cartilage-derived peptides in patients with AS.
METHODS: An HLA-B27-binding prediction program and a proteasome-cutting prediction program for the human 20S proteasome were used to screen 18 human cartilage proteins for potentially immunogenic nonamer peptides. The peptides identified were used to stimulate peripheral blood mononuclear cells from 20 HLA-B27-positive patients with AS and synovial fluid (SF) mononuclear cells from 7 HLA-B27-positive patients with AS. Activation of T cells was measured by antigen-specific intracellular cytokine staining and quantified by flow cytometry.
RESULTS: From the screening analysis, we identified 121 nonamer peptides. Of these, 1 peptide derived from type II collagen and 1 from type VI collagen were stimulatory for peripheral blood CD8+ T cells in only 1 of 20 patients. However, in 4 of 7 SF samples the same type VI collagen-derived nonamer peptide stimulated SF CD8+ T cells, but none of the other peptides was stimulatory. This CD8+ T cell response could be blocked by an anti-HLA-B27 antibody, confirming an HLA-B27-restricted immune response.
CONCLUSION: Our findings suggest that cartilage-directed cellular autoimmunity might play an important role in joint-specific tissue damage in patients with AS. Future research is necessary to determine whether the identified peptide is of pathogenetic relevance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15751060     DOI: 10.1002/art.20948

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  26 in total

1.  Pathophysiology of spondyloarthritis.

Authors:  Monika Ronneberger; Georg Schett
Journal:  Curr Rheumatol Rep       Date:  2011-10       Impact factor: 4.592

2.  Endoplasmic reticulum aminopeptidase-1 alleles associated with increased risk of ankylosing spondylitis reduce HLA-B27 mediated presentation of multiple antigens.

Authors:  Sergey S Seregin; David P W Rastall; Irini Evnouchidou; Charles F Aylsworth; Dionisia Quiroga; Ram P Kamal; Sarah Godbehere-Roosa; Christopher F Blum; Ian A York; Efstratios Stratikos; Andrea Amalfitano
Journal:  Autoimmunity       Date:  2013-09-13       Impact factor: 2.815

Review 3.  Pathogenesis of spondyloarthritis: insights from synovial membrane studies.

Authors:  Leen De Rycke; Elli Kruithof; Bernard Vandooren; Paul P Tak; Dominique Baeten
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

4.  The Human Leukocyte Antigen (HLA)-B27 Peptidome in Vivo, in Spondyloarthritis-susceptible HLA-B27 Transgenic Rats and the Effect of Erap1 Deletion.

Authors:  Eilon Barnea; Dganit Melamed Kadosh; Yael Haimovich; Nimman Satumtira; Martha L Dorris; Mylinh T Nguyen; Robert E Hammer; Tri M Tran; Robert A Colbert; Joel D Taurog; Arie Admon
Journal:  Mol Cell Proteomics       Date:  2017-02-10       Impact factor: 5.911

Review 5.  Experimental spondyloarthropathies: animal models of ankylosing spondylitis.

Authors:  Vyacheslav A Adarichev; Tibor T Glant
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

6.  Discovery of Selective Inhibitors of Endoplasmic Reticulum Aminopeptidase 1.

Authors:  Zachary Maben; Richa Arya; Digamber Rane; W Frank An; Shailesh Metkar; Marc Hickey; Samantha Bender; Akbar Ali; Tina T Nguyen; Irini Evnouchidou; Roger Schilling; Efstratios Stratikos; Jennifer Golden; Lawrence J Stern
Journal:  J Med Chem       Date:  2019-12-30       Impact factor: 7.446

7.  Serum levels of IL-33 is increased in patients with ankylosing spondylitis.

Authors:  Guo-Wei Han; Li-Wen Zeng; Chun-Xiang Liang; Bai-Ling Cheng; Bing-Sheng Yu; Hao-Miao Li; Fang Fang Zeng; Shao-Yu Liu
Journal:  Clin Rheumatol       Date:  2011-10-04       Impact factor: 2.980

8.  Programmed cell death 1 gene polymorphisms is associated with ankylosing spondylitis in Chinese Han population.

Authors:  Xiang Liu; Li-Hua Hu; Yi-Rong Li; Feng-Hua Chen; Yong Ning; Qun-Feng Yao
Journal:  Rheumatol Int       Date:  2009-12-12       Impact factor: 2.631

9.  Recombinant Salmonella typhimurium outer membrane protein A is recognized by synovial fluid CD8 cells and stimulates synovial fluid mononuclear cells to produce interleukin (IL)-17/IL-23 in patients with reactive arthritis and undifferentiated spondyloarthropathy.

Authors:  S Chaurasia; A K Shasany; A Aggarwal; R Misra
Journal:  Clin Exp Immunol       Date:  2016-05-23       Impact factor: 4.330

10.  Aberrant expression of microRNAs in T cells from patients with ankylosing spondylitis contributes to the immunopathogenesis.

Authors:  N-S Lai; H-C Yu; H-C Chen; C-L Yu; H-B Huang; M-C Lu
Journal:  Clin Exp Immunol       Date:  2013-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.